Dr. Ilana Juliett Deluca, MD

Dr. Deluca practices at Medical Faculty Associates, Inc in Washington, District of Columbia.

Dr. Deluca's NPI, 1174812614, was assigned on April 5, 2011. Dr. Deluca holds New York license 279391.

Dr. Deluca's primary practice is Medical Faculty Associates, Inc, at 2150 Pennsylvania NW Ave, Washington, DC 20037 in District Of Columbia County. The practice phone is (202) 741-3350.

Dr. Deluca's primary practice is Medical Faculty Associates, Inc in Washington, District of Columbia. The medical group on file is The GW Medical Faculty Associates. Dmand AI also links Dr. Deluca to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deluca practices. Vendor and product names are available with a free account.

Dermatology is Dr. Deluca's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Deluca is board certified in dermatology by the American Board of Dermatology. Dr. Deluca is licensed in New York.

CMS data shows 850 Medicare services from Dr. Deluca across 11 procedure codes in 2024, for 375 Medicare patients. Medicare paid $62,119 for them. Every service was in an office.

CMS counts 375 Medicare patients who saw Dr. Deluca in 2024. The largest group is 65 to 74, with 190 patients. 74% of them have high cholesterol, and 57% have high blood pressure. 19% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deluca's median patient age at 54, with 63% women.

In 2024, Dr. Deluca wrote 538 Medicare Part D claims for 170 patients. 80% of them were for generic drugs. CMS names the drug for 385 of them, across 12 drugs with 11 or more claims each, at $77,860 in total drug cost. In 2023, CMS named 346 claims across 9 drugs.

Dr. Deluca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 190 procedures of removal of skin lesions by Dr. Deluca, more than 79% of the clinicians it reports for that procedure.

CMS Open Payments shows 201 general payments to Dr. Deluca from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,315.